Product Information
FENOFIBRATE 134 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1141 per EA under NDC 59651020201. Its NADAC has been published 183 times since Dec 28, 2022.
Strength
134 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651020201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA212232On Market Since
9/20/2021
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 134 MG CAPSULE has been published 183 times since Dec 28, 2022, and over the history we have for it it has declined 14.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1141 per EA |
|---|---|
| All-time high | $0.1517 (Feb 14, 2024) |
| All-time low | $0.1020 (Nov 20, 2024) |
| 52-week high | $0.1391 |
| 52-week low | $0.1101 |
| Median price | $0.1295 |
| Average price | $0.1276 |
| Largest weekly change | -28.2% (Feb 21, 2024) |
| Weeks tracked | 183 |
| Tracking since | Dec 28, 2022 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 134 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 134 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1141 per EA (NDC 59651020201), effective Jun 24, 2026.
How has the price of FENOFIBRATE 134 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 134 MG CAPSULE has declined 14.1%. It has been tracked across 183 weekly CMS publications since Dec 28, 2022.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 134 MG CAPSULE?
Since Dec 28, 2022, the NADAC for FENOFIBRATE 134 MG CAPSULE has ranged from a low of $0.1020 (Nov 20, 2024) to a high of $0.1517 (Feb 14, 2024), with a median of $0.1295 per EA.
Are there cheaper alternatives to FENOFIBRATE 134 MG CAPSULE?
5 NADAC-published products share the same active ingredient, strength, and dosage form as FENOFIBRATE 134 MG CAPSULE, but none are currently priced below it.
Who manufactures FENOFIBRATE 134 MG CAPSULE?
FENOFIBRATE 134 MG CAPSULE (NDC 59651020201) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification